THROMBOTIC MICROANGIOPATHIES
Clinical trials for THROMBOTIC MICROANGIOPATHIES explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHIES trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a needle replace a machine? new study aims to simplify lifesaving iTTP treatment
Disease control Recruiting nowThis study tests whether a simpler treatment for immune thrombotic thrombocytopenic purpura (iTTP) works as well as the standard approach. Instead of daily plasma exchange (an invasive procedure), patients receive plasma infusions, immune-suppressing drugs, and caplacizumab. The …
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Blood test could unlock precision medicine for deadly TMA
Diagnosis Recruiting nowThis study is testing a new blood test (the HMEC test) to see if it can better identify which patients with thrombotic microangiopathy (TMA) have a specific immune system problem driving their disease. TMA is a severe condition that damages kidneys and the brain. The researchers …
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Sponsor: Maastricht University Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New study aims to detect lung damage earlier in young transplant patients
Knowledge-focused Recruiting nowThis study follows 2,000 children who receive stem cell transplants to better understand and detect lung injuries that can occur after the procedure. Researchers will track participants for two years, collecting samples and health data to find ways to diagnose problems earlier. T…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Massive study aims to unlock secrets of rare blood disorder
Knowledge-focused Recruiting nowThis study reviews medical records from over 1,200 people with immune thrombotic thrombocytopenic purpura (iTTP), a rare and life-threatening blood disorder. The goal is to understand long-term health problems, such as heart disease and thinking issues, that survivors face. By an…
Matched conditions: THROMBOTIC MICROANGIOPATHIES
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC